Digestive and Liver Disease
Volume 41, Issue 8 , Pages 599-604 , August 2009

Alcohol and coffee drinking and smoking habit among subjects with HCV infection

  • C. Zani

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • ,
  • F. Donato

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • Corresponding Author InformationCorresponding author at: Sezione di Igiene, Epidemiologia e Sanità Pubblica, Università di Brescia, Facoltà di Medicina e Chirurgia, Viale Europa 11, 25123 Brescia, Italy. Tel.: +39 030 3838602; fax: +39 030 370 1404.
    • ,
  • M. Chiesa

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • ,
  • C. Baiguera

      Affiliations

    • Liver Unit of the Infectious Diseases Department, Spedali Civili, Brescia, Italy
    • ,
  • U. Gelatti

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • ,
  • L. Covolo

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • ,
  • M.G. Antonini

      Affiliations

    • Liver Unit of the Infectious Diseases Department, Spedali Civili, Brescia, Italy
    • ,
  • P. Nasta

      Affiliations

    • Liver Unit of the Infectious Diseases Department, Spedali Civili, Brescia, Italy
    • ,
  • F. Gatti

      Affiliations

    • Liver Unit of the Infectious Diseases Department, Spedali Civili, Brescia, Italy
    • ,
  • G. Orizio

      Affiliations

    • Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Brescia, Italy
    • ,
  • M. Puoti

      Affiliations

    • Liver Unit of the Infectious Diseases Department, Spedali Civili, Brescia, Italy

Received 28 July 2008 ,Accepted 20 November 2008.

References 

  1. IARC. Alcohol Drinking. Monographs on the Evaluation of Carcinogenic Risks Humans. 44;1988:1–378.
  2. Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004;24:217–232
  3. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127:S87–S96
  4. IARC. Tobacco smoke and involuntary smoking. Monographs on the Evaluation of Carcinogenic Risks to Humans 2004;83:679–710.
  5. Corrao G, et al. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001;11:458–465
  6. Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case–control study. J Hepatol. 2005;42:528–534
  7. Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol. 2005;3:1260–1268
  8. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36:S35–S46
  9. Peters MG, Terrault NA. Alcohol use and hepatitis C. Hepatology. 2002;36:S220–225
  10. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–832
  11. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323–331
  12. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology. 1998;27:914–919
  13. Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, et al. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology. 2006;130:1912–1914
  14. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001;34:121–125
  15. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut. 2003;52:126–129
  16. Loguercio C, Di Pierro M, Di Marino MP, Federico A, Disalvo D, Crafa E, et al. Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects. Alcohol Alcoholism. 2000;35:296–301
  17. Strader DB, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147–1171
  18. Donato F, Boffetta P, Fazioli R, Gelatti U, Porru S. Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case–control study. Eur J Epidemiol. 1998;14:259–267
  19. Amstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. New York: Oxford Medical Publications; 1992;
  20. Dunn G. Design and analysis of reliability studies. New York: Oxford University Press; 1989;
  21. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991;
  22. Thompson WG, Walter DW. A reappraisal of the kappa coefficient. J Clin Epidemiol. 1988;41:949–958
  23. Feinstein AR, Cicchetti DV. High agreement but low kappa. I. The problems of two paradoxes. J Clin Epidemiol. 1990;43:543–549
  24. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med. 1998;17:101–110
  25. Stroffolini T, et al. Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases. J Viral Hepat. 2006;13:351–354
  26. Istituto nazionale di statistica, Indicatori socio-sanitari [in Italian] http://www.istat.it/sanita/sociosan/.
  27. European Commission, European statistic data on population and social conditions http://epp.eurostat.ec.europa.eu/.
  28. Ferraroni M, Decarli A, Franceschi S, La Vecchia C, Enard L, Negri E, et al. Validity and reproducibility of alcohol consumption in Italy. Int J Epidemiol. 1996;25:775–782
  29. Ferraroni M, Tavani A, Decarli A, Franceschi S, Parpinel M, Negri E, et al. Reproducibility and validity of coffee and tea consumption in Italy. Eur J Clin Nutr. 2004;58:674–680
  30. D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D. Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology. 1996;7:312–315
  31. Rehm J. Measuring quantity, frequency, and volume of drinking. Alcohol Clin Exp Res. 1998;22:4S–14S
  32. Corrao G, Busellu M, Valenti M, Torchio P, Galatola G, Di Orio F. Reproducibility of measuring lifetime alcohol consumption. Alcologia. 1994;6:127–135
  33. Inoue M, et al. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer I. 2005;97:293–300
  34. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3:375–381
  35. Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi H, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case–control study. Hepatol Res. 2006;36:201–208
  36. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther. 2007;26:1–8
  37. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol. 1998;27:438–443
  38. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology. 2008;48:129–136
  39. Yuen ST, Gogo AR, Luk IS, Cho CH, Ho JC, Loh TT. The effect of nicotine and its interaction with carbon tetrachloride in the rat liver. Pharmacol Toxicol. 1995;77:225–230

PII: S1590-8658(08)00857-8

doi: 10.1016/j.dld.2008.11.018

Digestive and Liver Disease
Volume 41, Issue 8 , Pages 599-604 , August 2009

Article Tools